Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11865609 | chr16:1691281 | G/T | 0 | 178 | 24.7 | 30.25 | 2.93 | KM Plot |
PCPG | rs11865689 | chr16:1764382 | T/C | 7.41E-5 | 172 | 25.6 | 15.85 | 17.77 | KM Plot |
PCPG | rs11866502 | chr16:1692378 | G/A | 0 | 177 | 25.47 | 27.33 | 2.65 | KM Plot |
PCPG | rs11866796 | chr16:85224451 | T/G | 0.000191 | 170 | 25.17 | 34.47 | 17.83 | KM Plot |
PCPG | rs11884669 | chr2:24329705 | G/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs11886838 | chr2:24318236 | C/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs11887770 | chr2:24301703 | G/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs11890987 | chr2:24296100 | C/T | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs11902776 | chr2:24297264 | G/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs11914096 | chr22:50219351 | G/A | 0.000157 | 177 | 25.67 | 23.88 | 15.18 | KM Plot |
PCPG | rs11915635 | chr3:80547427 | G/A | 6.87E-5 | 176 | 19.87 | 24.03 | 27.2 | KM Plot |
PCPG | rs11918372 | chr3:80545136 | A/G | 8.52E-5 | 178 | 27.43 | 22.63 | 25.17 | KM Plot |
PCPG | rs11921862 | chr3:80558382 | G/A | 2.79E-5 | 177 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs11921869 | chr3:80558545 | C/T | 2.79E-5 | 177 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs11928688 | chr3:80558294 | A/G | 2.79E-5 | 177 | 19.53 | 24.77 | 27.2 | KM Plot |